Julia Chapman
Corporate Officer/Principal bei BridgeBio Pharma LLC
Profil
Julia Chapman is currently working as the Vice President of Business Development & Strategy at BridgeBio Pharma LLC.
Previously, she worked as the Senior Vice President of Corporate Strategy & Planning at Verve Therapeutics, Inc. Ms. Chapman completed her undergraduate degree and earned an MBA from Duke University.
Aktive Positionen von Julia Chapman
Unternehmen | Position | Beginn |
---|---|---|
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Julia Chapman
Unternehmen | Position | Ende |
---|---|---|
VERVE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Julia Chapman
Duke University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VERVE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Health Technology |